109 related articles for article (PubMed ID: 17188135)
1. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival.
Givi B; Pommier SJ; Thompson AK; Diggs BS; Pommier RF
Surgery; 2006 Dec; 140(6):891-7; discussion 897-8. PubMed ID: 17188135
[TBL] [Abstract][Full Text] [Related]
2. Comment on "Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases".
Li X; Liu L
J Surg Oncol; 2024 Feb; 129(2):449-450. PubMed ID: 37818827
[No Abstract] [Full Text] [Related]
3. Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME; Pavel M; Ćwikła JB; Phan AT; Raderer M; Sedláčková E; Cadiot G; Wolin EM; Capdevila J; Wall L; Rindi G; Langley A; Martinez S; Blumberg J; Ruszniewski P;
N Engl J Med; 2014 Jul; 371(3):224-33. PubMed ID: 25014687
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Rinke A; Müller HH; Schade-Brittinger C; Klose KJ; Barth P; Wied M; Mayer C; Aminossadati B; Pape UF; Bläker M; Harder J; Arnold C; Gress T; Arnold R;
J Clin Oncol; 2009 Oct; 27(28):4656-63. PubMed ID: 19704057
[TBL] [Abstract][Full Text] [Related]
6. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
[TBL] [Abstract][Full Text] [Related]
7. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.
Capurso G; Rinzivillo M; Bettini R; Boninsegna L; Delle Fave G; Falconi M
Br J Surg; 2012 Nov; 99(11):1480-6. PubMed ID: 22972490
[TBL] [Abstract][Full Text] [Related]
9. Surgery Improves Patient-Reported Outcomes in Patients with Intestinal and Pancreatic NETs: A Prospective Analysis.
Rosowicz A; Bangla VG; Johnson JW; Olson L; Chen J; Divino CM
Ann Surg Oncol; 2023 Oct; 30(11):6777-6785. PubMed ID: 37349613
[TBL] [Abstract][Full Text] [Related]
10. Surgical aspects of small intestinal neuroendocrine tumors.
Kupietzky A; Dover R; Mazeh H
World J Gastrointest Surg; 2023 Apr; 15(4):566-577. PubMed ID: 37206065
[TBL] [Abstract][Full Text] [Related]
11. Small bowel neuroendocrine tumors: An analysis of clinical presentation, diagnostic workup and surgical approach-A single center retrospective study.
Kroepfl V; Bellotti R; Gasser E; Esswein K; Esser H; Kafka-Ritsch R; Öfner D; Perathoner A
Front Surg; 2023; 10():1072435. PubMed ID: 37077861
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question.
Dijke K; Kuhlmann KFD; Levy S; Tesselaar MET
Curr Oncol Rep; 2023 Jun; 25(6):679-688. PubMed ID: 37004701
[TBL] [Abstract][Full Text] [Related]
13. Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases.
Ngongoni R; Visser B
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291892
[TBL] [Abstract][Full Text] [Related]
14. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis.
Yang Z; Liang J; Leng K; Shi G
Front Oncol; 2022; 12():903560. PubMed ID: 35847865
[TBL] [Abstract][Full Text] [Related]
15. Primary hepatic neuroendocrine carcinoma with colon adenoma: A case report with literature review.
Wang Q; Zhang J; Xu L; Li X; Lu Y; Chen S; Jin Q
Int J Surg Case Rep; 2022 Jun; 95():107176. PubMed ID: 35636210
[TBL] [Abstract][Full Text] [Related]
16. Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms.
Morani AC; Gupta S; Elsayes KM; Mubarak AI; Khalaf AM; Bhosale PR; Sun J; Jensen CT; Kundra V
J Comput Assist Tomogr; 2022 May-Jun 01; 46(3):333-343. PubMed ID: 35575649
[TBL] [Abstract][Full Text] [Related]
17. Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors.
Shaib WL; Zakka K; Penley M; Jiang R; Akce M; Wu C; Maithel SK; Sarmiento JM; Kooby D; Behera M; Alese OB; El-Rayes BF
Pancreas; 2021 Nov-Dec 01; 50(10):1382-1391. PubMed ID: 35041337
[TBL] [Abstract][Full Text] [Related]
18. Genetic Drivers of Ileal Neuroendocrine Tumors.
Carpizo DR; Harris CR
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680217
[TBL] [Abstract][Full Text] [Related]
19. Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review.
Lan J; Guo D; Qin X; Chen B; Liu Q
Front Surg; 2021; 8():678853. PubMed ID: 34336917
[No Abstract] [Full Text] [Related]
20. Metastatic neuroendocrine tumor with metastases to the right liver in a patient with absent left portal vein.
Mahoney RC; Awad K; Maldini G
J Surg Case Rep; 2021 May; 2021(5):rjab207. PubMed ID: 34055294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
